FDA Approves New Diabetes Medication in 2014; Dapagliflozin (Farxiga)

Grunberger Diabetes Institute Diabetes Medications, Manage Diabetes FDA Approves New Diabetes Medication in 2014; Dapagliflozin (Farxiga)
0 Comments

FDA approved dapagliflozin (Farxiga) on January 8, 2014 for treatment of patients with type 2 diabetes not controlled with diet and exercise.

This medication is the second in the class of drugs which block reabsorption of glucose by the kidney and thus lower blood sugar by increasing its excretion in the urine.

Last year canagliflozin (Invokana) was approved as the first such drug in the US.

In addition to lowering blood sugar levels, many patients can lose weight (by losing calories in the urine). These pills are not associated with low blood sugar levels. However, they can increase risk of genital mycotic and urinary tract infections.

Categories:

Related Posts

Diabetes and Endocrinology and Public Health
Dr. George Grunberger of Grunberger Diabetes Institute had the honor of presenting Friday May 28th
What to Know About Zegalogue: A new glucagon rescue
Patients whose diabetes treatment includes insulin will experience hypoglycemic episodes, which occur when most people’s
How to Diagnose a Thyroid Condition
January is Thyroid Awareness Month, so it is only fitting we release an article with